1-5 of 5
Tarun Bhagnani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved Hematologic Recovery with Ivosidenib in Patients with mIDH1 Relapsed or Refractory MDS: Results from a Phase 1 Substudy

Gabrielle T. Prince, Praneeth Baratam, Guillermo Garcia-Manero, Anne Angiolillo, Tarun Bhagnani, Assaf Vestin, Amir T. Fathi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3226.
https://doi.org/10.1182/blood-2024-209071
Published: 2024
Journal Articles

Economic Burden Associated with Switching to Second Line Asparaginase (Recombinant Erwinia) in Pediatrics, Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL)

Meghan McCormick, Tina Gu, Tarun Bhagnani, Indrani Chatterjee, Arun Prashar, Ravi Potluri, Eros Papademetriou, Luke Maese
Journal: Blood
Blood (2024) 144 (Supplement 1): 7602.
https://doi.org/10.1182/blood-2024-210947
Published: 2024
Journal Articles

Patterns of Care Among Adolescents and Young Adults Treated for Acute Lymphoblastic Leukemia: A Retrospective Study across Diverse US Practices

Tarun Bhagnani, Michael Roth, Kristen M. O'Dwyer, Julie Wolfson, Indrani Chatterjee, Arun Prashar, Ravi Potluri, Eros Papademetriou, Robert Paglia, David Robert Freyer
Journal: Blood
Blood (2023) 142 (Supplement 1): 3704.
https://doi.org/10.1182/blood-2023-189553
Published: 2023
Journal Articles

Comparison of Overall Survival Among Adolescents and Young Adults (AYA) with Newly-Diagnosed Acute Lymphoblastic Leukemia (ALL) Treated with Pediatric-Inspired or Non-Pediatric Inspired Regimens: A Real-World Analysis Using Claims Data

Tarun Bhagnani, Jian J. Zhu, David Robert R. Freyer, Kristen M. O'Dwyer, Michael E. Roth, Julie A. Wolfson, Qian Meng, Rui Sammi Tang, Robert G. Paglia
Journal: Blood
Blood (2022) 140 (Supplement 1): 2190–2192.
https://doi.org/10.1182/blood-2022-162681
Published: 2022
Journal Articles

Clinical Outcomes Among Real-World Patients with Chronic Lymphocytic Leukemia (CLL) Initiating First-Line Ibrutinib or Chemoimmunotherapy (CIT) Stratified By Risk Status: Results from a US Retrospective Chart Review Study

Qing Huang, PhD, Kathleen L Deering, Qing Harshaw, MD PhD, Tarun Bhagnani, MS, Lori A. Leslie, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–18.
https://doi.org/10.1182/blood-2020-136121
Published: 2020